• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Vietnam bird flu vaccine returns positive results

Shiloh

Editor, Senior Moderator
Source: http://www.radioaustralia.net.au/news/stories/200805/s2240038.htm?tab=latest

Vietnam bird flu vaccine returns positive results

Updated 1 hour 4 minutes ago

Vietnam says it has had good results with the first stage of human testing of its locally developed bird flu vaccine.

The vaccine, produced by the health ministry's vaccine and biotechnology company, Vabiotech, has been trialled on a group of thirty students from the Military Medical Institute.

Vabiotech began its study in 2004 as avian flu began to spread throughout Vietnam, and was given the all-clear to conduct human trials after successful tests on animals last year.

Vabiotech Director Thu Van has told Radio Australia's Connect Asia program over the past two months the vaccine has been tested on 10 volunteers close to the project, and now on another 30 people, and she is pleased with the process so far.

"On volunteers, clinical trials, phase one... it was safe, quite good," she said.

"The next injection is [in] about 10 days."

Further tests will be conducted on 300 medical students within the next 8 months, and Vabiotech hopes to introduce its product in late 2009.

The vaccine has been developed using monkey kidney cells - something D Sean Tobin, from the World Health Organization, says could make using the vaccine in other countries more difficult.

"Certainly there would be some extra level of scrutiny required, if they were to try and use this vaccine in other countries," he said.

"But Vabiotech do have a long experience with other kinds of vaccines using this monkey kidney cell technology, they feel, and the government here feels quite confident in those vaccines."
 
Back
Top